Home
HomeChat
Markets
AlertsCalendarScreenerCharts
Portfolio
WatchlistsPortfolioFiles
Account
Docs
Sign upJoinLog inLogin

Longeveron Inc. (LGVN) stock profile

Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.

Key facts

SymbolLGVN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CEOStephen H. Willard
Employees25
HeadquartersMiami, FL, US
IPO2021-02-12
Websitewww.longeveron.com

Explore LGVN on Vantafin

  • Longeveron Inc. Overview
  • Longeveron Inc. Financials
  • Longeveron Inc. News
  • Longeveron Inc. Events
  • Longeveron Inc. SEC filings
  • Longeveron Inc. Insider transactions
  • Longeveron Inc. Transcripts

Frequently asked questions

What does Longeveron Inc. (LGVN) do?
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells sourced from bone marrow of young healthy adult donors. It is conducting Phase 1 and 2 clinical trials in various indications, such as aging frailty, Alzheimer's disease, metabolic syndrome, acute respiratory distress syndrome, and hypoplastic left heart syndrome. The company was incorporated in 2014 and is based in Miami, Florida.
Where is LGVN stock listed?
Longeveron Inc. trades under the ticker LGVN on NASDAQ.
How can I research LGVN's financials and filings?
Vantafin provides Longeveron Inc.'s income statement, balance sheet and cash-flow data, SEC filings, earnings-call transcripts, and insider & institutional ownership on the LGVN profile.